About this blog
Welcome to the SAS Health and Life Sciences blog. We explore how the healthcare ecosystem – providers, payers, pharmaceutical firms, regulators and consumers – can collaboratively use information and analytics to transform health quality, cost and outcomes. I’m Jason Burke, Director of Health and Life Sciences here at SAS, and you can read more about me here.Subscribe to this blog
Archives
Alice Swearingen
RSS
Alice is currently a Principal Industry Consultant in the CHAI organization at SAS.
Alice has more than 20 years pharmaceutical experience at GlaxoSmithKline (GSK), where she most recently served as Vice President, Channel Development and Sales. During her career at GSK she gained experience in finance, pricing, managed markets, global pricing & reimbursement, and US marketing. She has a bachelor of science degree in business administration / accounting from Auburn University. Alice currently resides in Raleigh, North Carolina
Recent Posts
Consumer-friendly predictive analytics are the key to making CDHPs work
The new year, filled with New Year's resolutions and rolling your accumulated out of pocket health care expenses back to zero. In fourth quarter last year, most employees renewed ... Read More
Advanced analytics in commercial life science, the rewards offset the risks
Over the past ten years managed markets organizations have developed their own analytical capabilities to evaluate membership, portfolio and health coverage offerings. The results from these analytical ... Read More
Are your Account Managers equipped for the new healthcare?
I love watching college football! There is the ceremony and the rituals- both on and off the field. The mascots, a beautiful Fall day, and ... Read More
Innovation can get you noticed
Innovation can grab your attention- the length of attention varies by the audience, the level of interest, and the novelty. Innovation can occur on purpose, ... Read More
Managed markets' new smart car
Are you driving your managed markets business with the old family station wagon or a new smart car? You may think the answer is obvious, ... Read More
Spending the next pharmaceutical marketing dollar
Now more than ever, life science organizations are closely scrutinizing large dollar spends and marketing campaigns across brands and portfolios- sometimes opting to reduce or ... Read More

"Treat" patients with big data insights